Announced Wed, 1 Jul · 17:59 IST
Subsidiary drug license suspended for 2 days in Karnataka
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹817.35
prior close
₹819.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.1+0.2-0.2+0.7-0.0-0.2-0.4-0.8+0.3-12.4———
Up moveDown movePending
AI summary
Medplus subsidiary Optival Health Solutions received a 2-day drug license suspension for one store in Anjaneya Layout, Davanagere, Karnataka. Order issued by the Assistant Director, Drugs Control Administration, Davanagere Circle, received on June 30, 2026 under Rule 65 of the Drugs and Cosmetics Act, 1940. Estimated revenue loss is Rs 0.80 lacs (about Rs 80,000). Action is limited to a single store.
Likely market impact
Minimal financial impact, revenue loss of about Rs 80,000 from one store suspension. No material effect on overall operations.